These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

9504 related items for PubMed ID: 16599050

  • 1. Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.
    Besser MJ, Treves AJ, Itzhaki O, Hardan I, Nagler A, Papa MZ, Catane R, Winkler E, Shalmon-Zifroni B, Schachter J.
    Isr Med Assoc J; 2006 Mar; 8(3):164-8. PubMed ID: 16599050
    [Abstract] [Full Text] [Related]

  • 2. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
    Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N, Shalmon B, Hardan I, Catane R, Markel G, Apter S, Ben-Nun A, Kuchuk I, Shimoni A, Nagler A, Schachter J.
    Clin Cancer Res; 2010 May 01; 16(9):2646-55. PubMed ID: 20406835
    [Abstract] [Full Text] [Related]

  • 3. Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
    Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Schallmach E, Kubi A, Shalmon B, Hardan I, Catane R, Segal E, Markel G, Apter S, Nun AB, Kuchuk I, Shimoni A, Nagler A, Schachter J.
    J Immunother; 2009 May 01; 32(4):415-23. PubMed ID: 19342963
    [Abstract] [Full Text] [Related]

  • 4. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
    Lacreusette A, Lartigue A, Nguyen JM, Barbieux I, Pandolfino MC, Paris F, Khammari A, Dréno B, Jacques Y, Blanchard F, Godard A.
    J Pathol; 2008 Dec 01; 216(4):451-9. PubMed ID: 18798220
    [Abstract] [Full Text] [Related]

  • 5. Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy.
    Itzhaki O, Hovav E, Ziporen Y, Levy D, Kubi A, Zikich D, Hershkovitz L, Treves AJ, Shalmon B, Zippel D, Markel G, Shapira-Frommer R, Schachter J, Besser MJ.
    J Immunother; 2011 Mar 01; 34(2):212-20. PubMed ID: 21304398
    [Abstract] [Full Text] [Related]

  • 6. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
    Weber J, Atkins M, Hwu P, Radvanyi L, Sznol M, Yee C, Immunotherapy Task Force of the NCI Investigational Drug Steering Committee.
    Clin Cancer Res; 2011 Apr 01; 17(7):1664-73. PubMed ID: 21325070
    [Abstract] [Full Text] [Related]

  • 7. Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
    Whiteside TL.
    In Vivo; 1991 Apr 01; 5(6):553-9. PubMed ID: 1810438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B, Sadeghi A, Bengtsson M, Wagenius G, Tötterman TH.
    J Immunother; 2008 Sep 01; 31(7):633-43. PubMed ID: 18600181
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.
    Markel G, Cohen-Sinai T, Besser MJ, Oved K, Itzhaki O, Seidman R, Fridman E, Treves AJ, Keisari Y, Dotan Z, Ramon J, Schachter J.
    Anticancer Res; 2009 Jan 01; 29(1):145-54. PubMed ID: 19331144
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.
    Chandran SS, Somerville RPT, Yang JC, Sherry RM, Klebanoff CA, Goff SL, Wunderlich JR, Danforth DN, Zlott D, Paria BC, Sabesan AC, Srivastava AK, Xi L, Pham TH, Raffeld M, White DE, Toomey MA, Rosenberg SA, Kammula US.
    Lancet Oncol; 2017 Jun 01; 18(6):792-802. PubMed ID: 28395880
    [Abstract] [Full Text] [Related]

  • 14. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
    Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL.
    N Engl J Med; 1990 Aug 30; 323(9):570-8. PubMed ID: 2381442
    [Abstract] [Full Text] [Related]

  • 15. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
    Besser MJ, Schallmach E, Oved K, Treves AJ, Markel G, Reiter Y, Schachter J.
    Cytotherapy; 2009 Aug 30; 11(2):206-17. PubMed ID: 19148842
    [Abstract] [Full Text] [Related]

  • 16. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
    Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P.
    Clin Cancer Res; 2012 Dec 15; 18(24):6758-70. PubMed ID: 23032743
    [Abstract] [Full Text] [Related]

  • 17. Targeting tumours by adoptive transfer of immune cells.
    Macary PA, Too CT, Dai X.
    Clin Exp Pharmacol Physiol; 2006 Dec 15; 33(5-6):569-74. PubMed ID: 16700896
    [Abstract] [Full Text] [Related]

  • 18. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
    Zheng M, Sun G, Cai S, Mueller R, Mrowietz U.
    Chin Med J (Engl); 1999 Jun 15; 112(6):493-6. PubMed ID: 11601324
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Jun 15; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 20. Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.
    Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US.
    World J Surg Oncol; 2012 Jun 22; 10():113. PubMed ID: 22726267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 476.